Sudarshan Pharma Industries Balance Sheet Health
Financial Health criteria checks 3/6
Sudarshan Pharma Industries has a total shareholder equity of ₹1.1B and total debt of ₹1.0B, which brings its debt-to-equity ratio to 93.9%. Its total assets and total liabilities are ₹2.8B and ₹1.7B respectively. Sudarshan Pharma Industries's EBIT is ₹224.5M making its interest coverage ratio 3.2. It has cash and short-term investments of ₹16.4M.
Key information
93.9%
Debt to equity ratio
₹1.05b
Debt
| Interest coverage ratio | 3.2x |
| Cash | ₹16.44m |
| Equity | ₹1.12b |
| Total liabilities | ₹1.71b |
| Total assets | ₹2.83b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543828's short term assets (₹2.4B) exceed its short term liabilities (₹1.6B).
Long Term Liabilities: 543828's short term assets (₹2.4B) exceed its long term liabilities (₹105.9M).
Debt to Equity History and Analysis
Debt Level: 543828's net debt to equity ratio (92.4%) is considered high.
Reducing Debt: 543828's debt to equity ratio has increased from 77.2% to 93.9% over the past 5 years.
Debt Coverage: 543828's debt is not well covered by operating cash flow (5.7%).
Interest Coverage: 543828's interest payments on its debt are well covered by EBIT (3.2x coverage).